Australia · Delayed Price · Currency is AUD IDT Australia Company Description
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the United States.
The company offers integrated services, including development, analytical testing, clinical packaging; and microbiological and analytical testing, clinical packaging, and pharmacy services.
It also provides formulation and manufacture of speciality orals (medicinal cannabis) and advanced therapies; psychedelics and medicinal cannabis; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms.
In addition, the company offers mRNA and antibody drug conjugates. Further, the company provides contract manufacturing services.
IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.
| Country | Australia |
| Founded | 1975 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 100 |
| CEO | Mark Simari |
Contact Details
Address: 45 Wadhurst Drive Boronia, VIC 3155 Australia | |
| Phone | 61 3 9801 8773 |
| Website | idtaus.com.au |
Stock Details
| Ticker Symbol | IDT |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000IDT0 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Robert Caunce | Director of Quality |